Flow Diverter Devices for the Treatment of Unruptured Vertebral Artery Dissecting Aneurysm
- PMID: 34689473
- PMCID: PMC8590915
- DOI: 10.3340/jkns.2021.0181
Flow Diverter Devices for the Treatment of Unruptured Vertebral Artery Dissecting Aneurysm
Abstract
Objective: Vertebral artery dissecting aneurysm (VADA) is a very rare subtype of intracranial aneurysms; when ruptured, it is associated with significantly high rates of morbidity and mortality. Despite several discussions and debates, the optimal treatment for VADA has not yet been established. In the last 10 years, flow diverter devices (FDD) have emerged as a challenging and new treatment method, and various clinical and radiological results have been reported about their safety and effectiveness. The aim of our study was to evaluate the clinical and radiological results with the use of FDD in the treatment of unruptured VADA.
Methods: We retrospectively evaluated the data of all patients with unruptured VADA treated with FDD between January 2018 and February 2021 at our hybrid operating room. Nine patients with unruptured VADA, deemed hemodynamically unstable, were treated with FDD. Among other parameters, the technical feasibility of the procedure, procedure-related complications, angiographic results, and clinical outcomes were evaluated.
Results: Successful FDD deployment was achieved in all cases, and the immediate follow-up angiography showed intra-aneurysmal contrast stasis with parent artery preservation. A temporary episode of facial numbness and palsy was noted in one patient; however, the symptoms had completely disappeared when followed up at the outpatient clinic 2 weeks after the procedure. The 3-6 months follow-up angiography (n=9) demonstrated complete/near-complete obliteration of the aneurysm in seven patients, and partial obliteration and segmental occlusion in one patient each. In the patient who achieved only partial obliteration, there was a sac 13 mm in size, and there was no change in the 1-year follow-up angiography. In the patient with segmental occlusion, the cause could not be determined. The clinical outcome was modified Rankin Scale 0 in all patients.
Conclusion: Our preliminary study using FDD to treat hemodynamically unstable unruptured VADA showed that FDD is safe and effective. Our study has limitations in that the number of cases is small, and it is not a prospective study. However, we believe that the study contributes to evidence regarding the safety and effectiveness of FDD in the treatment of unruptured VADA.
Keywords: Aneurysm, dissecting; Endovascular procedures; Intracranial aneurysm; Vertebral artery.
Conflict of interest statement
Dong Wuk Son has been editorial board of JKNS since November 2017. He was not involved in the review process of this original article. No potential conf lict of interest relevant to this article was reported.
Figures



References
-
- Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013;267:858–868. - PubMed
-
- CADISS trial investigators. Markus HS, Hayter E, Levi C, Feldman A, Venables G, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14:361–367. - PubMed
-
- Cohen JE, Gomori JM, Rajz G, Itshayek E, Eichel R, Leker RR. Urgent off-label use of the pipeline flow diverter stent in selected ischemic cerebrovascular conditions: thrombotic segments and tortuous arteries. J Neurointerv Surg. 2015;7:671–675. - PubMed
-
- Corley JA, Zomorodi A, Gonzalez LF. Treatment of dissecting distal vertebral artery (V4) aneurysms with flow diverters. Oper Neurosurg (Hagerstown) 2018;15:1–9. - PubMed
-
- Dabus G, Lin E, Linfante I. Endovascular treatment of fusiform intracranial vertebral artery aneurysms using reconstructive techniques. J Neurointerv Surg. 2014;6:589–594. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources